Phase 4 N=50 Functional Performance of the Journey Deuce Bicompartmental Versus the Genesis II Total Knee System
Knee Arthroplasty
Primary: 2-Year Knee Society Score — 91.3; 94.2 units on a scale 0-100
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 4 N=40 Comparison of Excision Versus Punch Incision in the Treatment of Epidermal Cysts
Epidermal Cyst
Primary: Number of Participants With Cyst Recurrence — 3; 2 participants
Phase 4 N=235 Evaluation of Relapse, Efficacy and Safety of Long-term Treatment With Oracea® vs Placebo
Rosacea
Primary: Period 2: Number of Subjects Who Relapsed — 4; 10; 8; 14 participants
Phase 4 N=36 A Study of MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to Anti-TNF Agents.
Rheumatoid Arthritis
Primary: Change From Baseline in Disease Activity Score Based on 28-Joint Count (DAS28) — 5.51; 4.39; -1.12 scores on a scale — p=<0.0001
Phase 4 N=10 Aerosolized Beta-Agonist Isomers in Asthma
Asthma
Primary: Change in Maximum Forced Expiratory Volume at One Second (FEV1) — 20; 20; 20; 19 percentage of change
Phase 4 N=100 Evaluation of Daptomycin for the Emergency Department Treatment of Complicated Skin and Skin Structure Infections
Cellulitis · Skin Infections
Primary: Satisfaction of Discharge Criteria — 15; 14 participants
Phase 4 N=24 Tilt-Table Study of the Clinical Efficacy of Midodrine in Symptomatic Orthostatic Hypotension
Orthostatic Hypotension
Primary: Time to Onset of Syncope/Near Syncope While on Tilt Table — 1105.6; 1626.6 seconds — p=0.0131
Phase 4 N=90 A Study to Evaluate the NSAIDS Sparing Effect of Etanercept in Subjects With Axial Spondyloarthritis
Axial Spondyloarthritis
Primary: Change From Baseline in Non Steroidal Anti Inflammatory Drug (NSAID) Assessment of the SpondyloArthritis International Society (ASAS) Score at Week 8. — -63.90; -36.63…
Phase 4 N=21 Zoledronic Acid Administration in Acute Spinal Cord Injury
Disuse Osteoporosis
Primary: Bone Mineral Density (BMD) at the Distal Femur and Proximal Tibia at Baseline and Month 12. — 1.102; 1.134; 0.898; 1.038 g/cm2
Phase 4 N=441 Study of Continuous Cardiac Monitoring to Assess Atrial Fibrillation After Cryptogenic Stroke
Cryptogenic Symptomatic Transient Ischemic Attack · Cryptogenic Ischemic Stroke
Primary: AF Detection Rate Within 6 Months — 8.9; 1.4 percentage of participants — p=0.0006
Phase 4 N=324 An Efficacy Study of Chlorhexidine Mouthwashes
Gingivitis
Primary: Gingival Severity Index (GSI) Based on the Gingival Index (GI) — 0.152; 0.143; 0.212 Units on a scale — p=<0.0001
Phase 4 N=74 ALiskiren or Losartan Effects on bioMARKers of Myocardial Remodeling
Hypertension · Left Ventricle Hypertrophy
Primary: Change From Baseline in C-terminal Propeptide of Procollagen Type I (PICP) — -5.22; -4.25 ug/l
Phase 4 N=737 A 6 Month Safety Study Of Ciclesonide Nasal Aerosol (Zetonna®) And Ciclesonide Nasal Spray (Omnaris®) In Subjects 12 Years And Older With Perennial Allergic Rhinitis (PAR)
Perennial Allergic Rhinitis
Primary: The Number of Subjects Experiencing Nasal Mucosal Disorders, Septum Disorders, or Nasal Septum Perforations as Treatment Emergent Adverse Events (AEs; TEAE) — 3; 4; 2; 0…
Phase 4 N=56 Cutivate Lotion HPA Axis Pediatric Study
Atopic Dermatitis
Primary: Post Treatment Serum Cortisol Values Will be Compared. — 1 participants
Phase 4 N=117 Foley Bulb With Low Dose Pitocin Versus Foley Bulb With a Standard Incremental Infusion Protocol for the Induction of Labor
Induction of Labor
Primary: Time to the Second Stage of Labor — 18.2; 14.6 hours